Skip to main content
TipRanks
Go Ultimate75% OFF

Madrigal Pharmaceuticals (YDO1) Q2 2024 Earnings Report

1 Followers

DE:YDO1 Q2 2024 EPS Results

Actual EPS
-EUR 6.40
Consensus EPS
-EUR 6.79
Beat/Miss
Beat by +EUR 0.39
One Year Ago EPS
-EUR 4.23

DE:YDO1 Q2 2024 Revenue Results

Actual Revenue
EUR 13.19M
Expected Revenue
EUR 3.83M
Beat/Miss
Beat by +EUR 9.36M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2024
Date
08/07/2024
Time
Before Open
Conference Call
Wednesday, August 7, 2024
DE:YDO1 Upcoming Earnings

Madrigal Pharmaceuticals's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

DE:YDO1 Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:YDO1 Earnings History

DE:YDO1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 25, 20272026 (Q4)1.29--2.32――
Nov 03, 20262026 (Q3)-0.781.65-4.58136.02% (+6.23)
Jul 30, 20262026 (Q2)-2.41-1.79-1.71-4.74% (-0.08)
May 06, 20262026 (Q1)-3.81-2.93-2.992.11% (+0.06)
Feb 19, 20262025 (Q4)-0.81-2.32-2.445.17% (+0.13)
Nov 04, 20252025 (Q3)-2.06-4.58-4.43-3.25% (-0.14)
Aug 05, 20252025 (Q2)-3.20-1.71-6.473.24% (+4.69)
May 01, 20252025 (Q1)-3.38-2.99-6.6555.01% (+3.66)
Feb 26, 20252024 (Q4)-3.53-2.44-5.1252.29% (+2.68)
Oct 31, 20242024 (Q3)-6.08-4.43-4.817.87% (+0.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed